Zofran Articles
UK FIRMS BOOSTED BY YEAR-END US APPROVALS
4 January 1993
SMITHKLINE BEECHAM ON TRACK
21 December 1992
ONDANSETRON LINKED TO CARDIAC ARREST
9 November 1992
EUROPE STOCK COMMENT
7 September 1992
GLAXO PROSPECTS GLOOM: FACT OR FICTION?
3 August 1992
SCHERING-PLOUGH IN UK CANCER DRUG DEAL
6 July 1992
Anti-emetics in chemotherapy
15 June 1992
STOCK MARKET COMMENTARY: EUROPE
18 May 1992
ZOFRAN APPROVED IN UK FOR PONV
11 May 1992
POST-ELECTION OUTLOOK FOR UK HEALTH SECTOR
20 April 1992
COMPARATIVE STUDY CALL WITH ZOFRAN
23 March 1992
FRANCE PROBES GLAXO'S IMIGRAN PROMOTION
23 March 1992
NEW CHEMICAL ENTITIES UPDATE FOR 1991
10 February 1992
ALZHEIMER'S DISEASE: A GROWING BURDEN
20 January 1992
GLAXO INCREASES CNS EMPHASIS IN USA
13 January 1992
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
